Midi Health Surpasses $1B Valuation, Igniting a New Era for Women’s Health
Midi Health, the fastest growing women’s telehealth company, today announced it raised $100 million in a Series D financing round led by Goodwater Capital with participation from new investors Foresite Capital and Serena Ventures, as well as continued support from Advance Venture Partners, GV (Google Ventures), Emerson Collective, SemperVirens, McKesson Ventures, and Felicis Ventures. The round values the company at over $1 billion, marking a pivotal moment for a long-ignored segment of healthcare.
Midi Health Introduces Testosterone Therapy for Women to Meet Explosive Patient Demand
Midi Health, one of the fastest-growing virtual clinics dedicated to women navigating midlife, is expanding access to testosterone hormone therapy, a treatment that plays a critical role in maintaining women’s libido, energy, mood, and cognitive function following a surge in demand across its 200,000+ patient network.
